- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06826976
Influence of Sensory Electrical Stimulation on Hand Functions in Chronic Stroke Patients (SES-Hand)
This study investigates the impact of sensory electrical nerve stimulation (SENS) on hand function in chronic stroke patients. Thirty participants were randomly divided into two groups:
Study Group (A): Received SENS combined with task-specific training.
Control Group (B): Received only task-specific training.
Assessments conducted before and after the intervention included measurements of grip strength, pinch strength, wrist range of motion, and performance on the Action Research Arm Test (ARAT).
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This study explores the effectiveness of sensory electrical nerve stimulation (SENS) in enhancing hand function among chronic stroke patients. Thirty participants were randomly divided into two groups:
Study Group (A): Received SENS combined with task-specific training.
Control Group (B): Received only task-specific training.
Assessment Methods:
Before and after the intervention, both groups underwent evaluations using:
Grip Dynamometer: To measure grip strength.
Pinch Dynamometer: To assess pinch strength.
Digital Goniometer: To determine wrist flexion and extension range of motion.
Action Research Arm Test (ARAT): To evaluate upper limb functional performance.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Giza, Egypt, 11835
- Cairo University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Patients who have experienced their first-ever ischemic stroke in the carotid system domain.
- Age range: 40 to 65 years old.
- Duration of illness: 30 to 180 days since stroke onset.
- Spasticity of the affected hand muscles (wrist flexors, finger flexors, and finger adductors) must be grade 1+ or less according to the Modified Ashworth Scale.
- Hand dysfunction severity ranges from mild to severe, defined by a score of ≤ 4 on the Medical Research Council Scale.
Exclusion Criteria:
- Presence of a deformity in the paralytic upper limb before the stroke.
- History of a lower motor neuron lesion in the impaired upper extremity (e.g., polyneuropathy) before the stroke.
- Skin abrasions or ulcerations on the affected upper limb.
- Unstable health conditions, including cardiac dysfunction, end-stage renal failure, unstable diabetes, or uncontrolled hypertension (>190/110).
- Presence of a pacemaker or other implanted electrically sensitive devices.
- Significant orthopedic conditions or chronic pain syndromes.
- Chronic use of medications that may influence motor or sensory excitability (e.g., anti-epileptic or antipsychotic drugs).
- Pregnancy.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Sensory electrical stimulation
received sensory electrical stimulation and task specific training program
|
peripheral sensory electrical stimulation on median, ulnar, and radial nerves of affected upper limb, simultaneously with Task Specific Training program which included four subtests of Action Research Arm Test scale.
|
|
Active Comparator: Task specific training
received task specific training program only.
Patients were tested pre and post treatment by Grip dynamometer, Pinch dynamometer, Digital goniometer and Action Research Arm Test Scale (ARAT).
|
received task specific training program only.
Patients were tested pre and post treatment by Grip dynamometer, Pinch dynamometer, Digital goniometer and Action Research Arm Test Scale (ARAT).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Hand grip strength
Time Frame: From enrollment to the end of treatment at end of 4th week
|
The patient seated with his/her shoulder adducted and naturally rotated, elbow flexed at 90 degrees, forearm in neutral position, and wrist between 0- and 30-degrees dorsiflexion and between 0- and 15-degrees ulnar deviation.
The Jamar hand dynamometer was set to the second handle position from the inside.
Lightly hold around the readout dial to prevent inadvertent dropping.
After the patient was positioned properly, the following statement was used "Squeeze as hard as you can….
harder …. harder….
relax" (16).
The scores of three successive trials were recorded for each tested hand.
The average score of three trials was compared to the normative data on the other side, which is in pounds.
|
From enrollment to the end of treatment at end of 4th week
|
|
wrist range of motion
Time Frame: From enrollment to the end of treatment at end of 4th week
|
Goniometer was used to assess wrist flexion-extension.
|
From enrollment to the end of treatment at end of 4th week
|
|
pinch strength
Time Frame: From enrollment to the end of treatment at end of 4th week
|
Three types of pinches were typically evaluated because they are involved in accomplishing occupational tasks and activities efficiently.
In Tip Pinch: The patient pinched the ends of the pinch meter between the tips of the thumb and index finger.
The test was administered by first giving the patient instructions and a demonstration, "Ready?
Pinch as hard as you can."
The patient was urged on as he or she attempted to pinch.
The average of three trials was recorded.
In Lateral Pinch (Key Pinch): The patient pinched the meter between the pad of the thumb and the lateral surface of the index finger.
In Palmar Pinch (Three-Jaw Chuck): The patient pinched the meter between the pad of the thumb and the pads of the index and middle fingers
|
From enrollment to the end of treatment at end of 4th week
|
|
hand functions
Time Frame: From enrollment to the end of treatment at end of 4th week
|
Patients who achieve a maximum score on the first (most difficult) item are credited with having scored 3 on all subsequent items on that scale.
If the patient scores less than 3 on the first item, then the second item is assessed.
This is the easiest item, and if patients score 0 then they are unlikely to achieve a score above 0 for the remainder of the items and are credited with a zero for the other items.
The maximum score on ARTS is 57 points (possible range 0 to 57).
|
From enrollment to the end of treatment at end of 4th week
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P.T. REC/012/005208
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on sensory electrical stimulation
-
Harran UniversityCompleted
-
Yeditepe UniversityCompletedHemiplegia | Stroke, Acute | Sensory DisordersTurkey
-
University of Texas, El PasoRecruitingInsulin ResistanceUnited States
-
University of Texas, El PasoRecruitingObesity | Overweight | Insulin ResistanceUnited States
-
Cairo UniversityRecruitingParkinson DiseaseEgypt
-
Pere ClaveHospital de GranollersCompletedStroke | Deglutition DisordersSpain
-
Creighton UniversityCompleted
-
Clinica Francisco Ortega Rehabilitacion Avanzada...Ionclinics & DEIONICS.CompletedLow Back Pain | Neck PainSpain
-
National Yang Ming UniversityCompleted
-
Baylor College of MedicineAvazzia, IncCompletedCOVID-19 | Muscle Weakness | Muscle AtrophyUnited States